STAT+: Gilead to buy cancer biotech Tubulis for more than $3 billion

Gilead is buying the German biotech Tubulis for more than $3 billion, a move that will expand its oncology pipeline.
Source
Stat News
Opens original article in a new tab
AI Bias Analysis
4 models · Takes ~15 seconds

Gilead is buying the German biotech Tubulis for more than $3 billion, a move that will expand its oncology pipeline.
Source
Stat News
Opens original article in a new tab

Even as therapies improve, a startling number of cancer patients are not getting genomic tests that could improve their chance of survival.

(MedPage Today) -- Note that some links may require registration or subscription. An interventional cardiologist who was fired filed a lawsuit against UPMC, alleging retaliation and violation of Pennsylvania's Whistleblower Act after he reported...

The FDA used the president’s budget to propose policies aimed at encouraging domestic development and manufacturing of drugs

(MedPage Today) -- The average pay increase for Medicare Advantage (MA) plans in 2027 will be 2.48%, a substantial increase from the 0.09% that the Centers for Medicare & Medicaid Services (CMS) originally proposed in January, agency officials...